Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Equity (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Return on Equity for 13 consecutive years, with 0.01% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 5.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 5.0% increase, with the full-year FY2025 number at 0.03%, up 13.0% from a year prior.
  • Return on Equity was 0.01% for Q4 2025 at Aytu Biopharma, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.02% in Q2 2025 to a low of 2.06% in Q2 2022.
  • A 5-year average of 0.56% and a median of 0.39% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: tumbled -131bps in 2022, then surged 163bps in 2023.
  • Aytu Biopharma's Return on Equity stood at 0.54% in 2021, then tumbled by -203bps to 1.63% in 2022, then soared by 79bps to 0.35% in 2023, then soared by 87bps to 0.04% in 2024, then soared by 114bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Return on Equity are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.02% (Q2 2025).